Publicaciones (12) Publicaciones en las que ha participado algún/a investigador/a

2001

  1. Anthocyanin-rich extract decreases indices of lipid peroxidation and DNA damage in vitamin E-depleted rats

    Free Radical Biology and Medicine, Vol. 31, Núm. 9, pp. 1033-1037

  2. Dietary gangliosides positively modulate the percentages of Th1 and Th2 lymphocyte subsets in small intestine of mice at weaning

    BioFactors, Vol. 15, Núm. 1, pp. 1-9

  3. Dietary long-chain polyunsaturated fatty acids from different sources affect fat and fatty acid excretions in rats

    Journal of Nutrition, Vol. 131, Núm. 12, pp. 3216-3221

  4. Efectos protectores de los ácidos grasos monoinsaturados y poliinsaturados sobre el desarrollo de la enfermedad cardiovascular

    Nutricion Hospitalaria, Vol. 16, Núm. 3, pp. 78-91

  5. Encefalopatías espongiformes transmisibles.: Bases moleculares, diagnóstico y perspectivas terapéuticas

    Ars pharmaceutica, Vol. 42, Núm. 1, pp. 5-20

  6. Feeding infant piglets formula with long-chain polyunsaturated fatty acids as triacylglycerols or phospholipids influences the distribution of these fatty acids in plasma lipoprotein fractions

    Journal of Nutrition, Vol. 131, Núm. 4, pp. 1250-1255

  7. Fortified foods. Criteria for vitamin supplementation in Spain

    Public Health Nutrition, Vol. 4, Núm. 6A, pp. 1331-1334

  8. Nutrientes condicionalmente esenciales

    Revista Espanola de Pediatria, Vol. 57, Núm. 337, pp. 13-26

  9. Paenibacillus jamilae sp. nov., an exopolysaccharide-producing bacterium able to grow in olive-mill wastewater

    International Journal of Systematic and Evolutionary Microbiology, Vol. 51, Núm. 5, pp. 1687-1692

  10. Plasma fatty-acid composition and antioxidant capacity in low birth-weight infants fed formula enriched with n-6 and n-3 long-chain polyunsaturated fatty acids from purified phospholipids

    Clinical Nutrition, Vol. 20, Núm. 1, pp. 69-76

  11. Rat hepatic stellate cells contribute to the acute-phase response with increased expression of α1 (I) and α1 (IV) collagens, tissue inhibitor of metalloproteinase-1, and matrix-metalloproteinase-2 messenger RNAs

    Hepatology, Vol. 33, Núm. 3, pp. 597-607

  12. Tratamiento, control y seguimiento farmacoterapéutico del paciente diabético

    Pharmaceutical care España, Vol. 3, Núm. 4, pp. 240-246